Xaciato Gel
Product Images NDC 78206-189

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Xaciato (NDC 78206-189). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Organon Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Carton (Carton)

Carton (Carton)
The image shows a flat layout of the XACIATO (clindamycin phosphate) vaginal gel, 2% packaging carton. It indicates an 8 g tube with a single 5 g applicator, highlighting single-dose use. The label includes storage instructions, contains barcodes, notes for intravaginal use only, and lists inactive ingredients. Distributed by Organon LLC, Jersey City, NJ.*
FDA Label Image

Figure-a (Figure A)

Figure-a (Figure A)
Illustration showing a tube, an empty applicator with a labeled plunger and black line, and a filled applicator with a grip, tip, and black line on the plunger just outside the applicator. The diagram details how the applicator fills from the tube end and identifies key applicator components.*
FDA Label Image

Figure-b (Figure B)

Figure-b (Figure B)
An instructional illustration showing two steps of using a vaginal gel applicator for XACIATO (clindamycin phosphate) 100 mg/5g gel. Figure B1 depicts a hand twisting the cap to open the applicator tube, and Figure B2 shows a hand removing the cap from the applicator.*
FDA Label Image

Figure-c (Figure C)

Figure-c (Figure C)
Instructional line drawing illustrating how to prepare and fill a vaginal gel applicator for XACIATO clindamycin phosphate vaginal gel. The four-step sequence shows removing the cap, attaching the plunger, pulling the plunger to fill the applicator, and a close-up indicating the proper fill line for the gel dose.*
FDA Label Image

Figure-d (Figure D)

Figure-d (Figure D)
An instructional diagram labeled Figure D showing a person lying on their back with knees bent and feet flat on the surface, demonstrating a position potentially related to the use or application of a vaginal gel medication.*
FDA Label Image

Figure-e (Figure E)

Figure-e (Figure E)
An instructional anatomical illustration labeled Figure E showing a hand inserting a vaginal gel applicator. The diagram identifies the urinary opening, vagina, and rectum to guide proper placement of the vaginal gel product.*
FDA Label Image

Figure-f (Figure F)

Figure-f (Figure F)
An anatomical illustration labeled as Figure F showing female pelvic regions including the urinary opening, vagina, and rectum. A hand is shown inserting a gel applicator into the vagina, demonstrating proper vaginal gel application technique.*
FDA Label Image

Label (Label)

Label (Label)
Label for XACIATO (clindamycin phosphate) vaginal gel 2%, a human prescription drug by Organon LLC. The label states it is for intravaginal use only, not for ophthalmic, dermal, or oral use, and is Rx only. The net weight is 8 grams. Instructions for puncturing a tamper-resistant seal are included.*
FDA Label Image

Structure (Structure)

Structure (Structure)
Chemical structure of clindamycin phosphate, the active ingredient in XACIATO vaginal gel. The molecular diagram shows atoms and bonds including a phosphate group, chlorine, methyl groups, and a complex ring structure representative of the antibiotic compound.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.